We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-0.6%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$280M
AUM Growth
-$12.6M
Cap. Flow
-$11.9M
Cap. Flow %
-4.24%
Top 10 Hldgs %
55.57%
Holding
53
New
13
Increased
14
Reduced
5
Closed
20

Top Buys

Rank Stock Value
1
AEGR
Aegerion Pharmaceuticals
AEGR
+$14.5M
2
ENR icon
Energizer
ENR
+$11.5M
3
HAIN icon
Hain Celestial
HAIN
+$10.2M
4
VNDA icon
Vanda Pharmaceuticals
VNDA
+$8.68M
5
THC icon
Tenet Healthcare
THC
+$8.27M

Top Sells

Rank Stock Value
1
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$15.2M
2
XNPT
XENOPORT, INC.
XNPT
+$12.6M
3
KODK icon
Kodak
KODK
+$12.6M
4
BDBD
BOULDER BRANDS INC
BDBD
+$10.4M
5
PBY
PEP BOYS MANNY MOE& JACK
PBY
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 45.72%
2 Consumer Discretionary 14.08%
3 Consumer Staples 8.36%
4 Industrials 6.68%
5 Financials 2.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDBD
51
DELISTED
BOULDER BRANDS INC
BDBD
– –
-1,266,000
Closed -$10.4M
1 2
3

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q4 2015 Portfolio in Review

As of Q4 2015, Armistice Capital held 53 positions worth $280M, down 4.3% from $293M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital withdrew a net $11.9M in Q4 2015, closing 20 positions and reducing 5 holdings. Its most notable exit was Pernix Therapeutics Holdings, Inc., an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Armistice Capital opened a new position in Aegerion Pharmaceuticals worth $12.1M.

  • Armistice Capital's largest Q4 2015 buy was Aegerion Pharmaceuticals: 1,202,000 shares worth $12.1M.
  • Armistice Capital added most to Vanda Pharmaceuticals in Q4 2015, an estimated $8.68M increase.
  • Armistice Capital's biggest Q4 2015 reduction was XENOPORT, INC., cutting an estimated $12.6M.
  • Armistice Capital fully exited Pernix Therapeutics Holdings, Inc. in Q4 2015, selling an estimated $15.2M.
  • Armistice Capital's ten largest holdings make up 56% of its $280M portfolio in Q4 2015.
  • Armistice Capital opened 13 new positions and closed 20 in Q4 2015.
  • Armistice Capital's portfolio value fell 4.3% quarter-over-quarter to $280M.

Based on Armistice Capital's 13F filing for Q4 2015, filed 16 Feb 2016.